| Product Code: ETC10765675 | Publication Date: Apr 2025 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
Sweden`s pemetrexed import market in 2024 saw significant growth, with key exporting countries including Denmark, Belgium, Germany, Netherlands, and Italy. Despite the influx of imports, the market concentration, as measured by the Herfindahl-Hirschman Index (HHI), remained low, indicating a competitive landscape. The compound annual growth rate (CAGR) from 2020 to 2024 stood at a healthy 4.69%, with a notable growth spurt of 17.54% from 2023 to 2024, showcasing a robust demand for pemetrexed in Sweden.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Sweden Pemetrexed Market Overview |
3.1 Sweden Country Macro Economic Indicators |
3.2 Sweden Pemetrexed Market Revenues & Volume, 2021 & 2031F |
3.3 Sweden Pemetrexed Market - Industry Life Cycle |
3.4 Sweden Pemetrexed Market - Porter's Five Forces |
3.5 Sweden Pemetrexed Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.6 Sweden Pemetrexed Market Revenues & Volume Share, By Mechanism of Action, 2021 & 2031F |
3.7 Sweden Pemetrexed Market Revenues & Volume Share, By Combination Therapy, 2021 & 2031F |
3.8 Sweden Pemetrexed Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.9 Sweden Pemetrexed Market Revenues & Volume Share, By Administration Route, 2021 & 2031F |
4 Sweden Pemetrexed Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Sweden Pemetrexed Market Trends |
6 Sweden Pemetrexed Market, By Types |
6.1 Sweden Pemetrexed Market, By Indication |
6.1.1 Overview and Analysis |
6.1.2 Sweden Pemetrexed Market Revenues & Volume, By Indication, 2021 - 2031F |
6.1.3 Sweden Pemetrexed Market Revenues & Volume, By Non-Small Cell Lung Cancer, 2021 - 2031F |
6.1.4 Sweden Pemetrexed Market Revenues & Volume, By Mesothelioma, 2021 - 2031F |
6.1.5 Sweden Pemetrexed Market Revenues & Volume, By Breast Cancer, 2021 - 2031F |
6.1.6 Sweden Pemetrexed Market Revenues & Volume, By Colorectal Cancer, 2021 - 2031F |
6.1.7 Sweden Pemetrexed Market Revenues & Volume, By Pancreatic Cancer, 2021 - 2031F |
6.2 Sweden Pemetrexed Market, By Mechanism of Action |
6.2.1 Overview and Analysis |
6.2.2 Sweden Pemetrexed Market Revenues & Volume, By Antifolate, 2021 - 2031F |
6.2.3 Sweden Pemetrexed Market Revenues & Volume, By DNA Synthesis Inhibition, 2021 - 2031F |
6.2.4 Sweden Pemetrexed Market Revenues & Volume, By Enzyme Targeting, 2021 - 2031F |
6.2.5 Sweden Pemetrexed Market Revenues & Volume, By Cell Growth Suppression, 2021 - 2031F |
6.2.6 Sweden Pemetrexed Market Revenues & Volume, By Purine Synthesis Blockade, 2021 - 2031F |
6.3 Sweden Pemetrexed Market, By Combination Therapy |
6.3.1 Overview and Analysis |
6.3.2 Sweden Pemetrexed Market Revenues & Volume, By Platinum-Based Chemotherapy, 2021 - 2031F |
6.3.3 Sweden Pemetrexed Market Revenues & Volume, By Immunotherapy, 2021 - 2031F |
6.3.4 Sweden Pemetrexed Market Revenues & Volume, By Radiation Therapy, 2021 - 2031F |
6.3.5 Sweden Pemetrexed Market Revenues & Volume, By Personalized Medicine, 2021 - 2031F |
6.3.6 Sweden Pemetrexed Market Revenues & Volume, By Monoclonal Antibodies, 2021 - 2031F |
6.4 Sweden Pemetrexed Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 Sweden Pemetrexed Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.4.3 Sweden Pemetrexed Market Revenues & Volume, By Oncology Clinics, 2021 - 2031F |
6.4.4 Sweden Pemetrexed Market Revenues & Volume, By Specialty Clinics, 2021 - 2031F |
6.4.5 Sweden Pemetrexed Market Revenues & Volume, By Research Institutes, 2021 - 2031F |
6.4.6 Sweden Pemetrexed Market Revenues & Volume, By Pharmaceutical Companies, 2021 - 2031F |
6.5 Sweden Pemetrexed Market, By Administration Route |
6.5.1 Overview and Analysis |
6.5.2 Sweden Pemetrexed Market Revenues & Volume, By Intravenous, 2021 - 2031F |
6.5.3 Sweden Pemetrexed Market Revenues & Volume, By Injection, 2021 - 2031F |
6.5.4 Sweden Pemetrexed Market Revenues & Volume, By IV Infusion, 2021 - 2031F |
6.5.5 Sweden Pemetrexed Market Revenues & Volume, By Cancer Treatment Centers, 2021 - 2031F |
6.5.6 Sweden Pemetrexed Market Revenues & Volume, By Hospital Pharmacy, 2021 - 2031F |
7 Sweden Pemetrexed Market Import-Export Trade Statistics |
7.1 Sweden Pemetrexed Market Export to Major Countries |
7.2 Sweden Pemetrexed Market Imports from Major Countries |
8 Sweden Pemetrexed Market Key Performance Indicators |
9 Sweden Pemetrexed Market - Opportunity Assessment |
9.1 Sweden Pemetrexed Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.2 Sweden Pemetrexed Market Opportunity Assessment, By Mechanism of Action, 2021 & 2031F |
9.3 Sweden Pemetrexed Market Opportunity Assessment, By Combination Therapy, 2021 & 2031F |
9.4 Sweden Pemetrexed Market Opportunity Assessment, By End User, 2021 & 2031F |
9.5 Sweden Pemetrexed Market Opportunity Assessment, By Administration Route, 2021 & 2031F |
10 Sweden Pemetrexed Market - Competitive Landscape |
10.1 Sweden Pemetrexed Market Revenue Share, By Companies, 2024 |
10.2 Sweden Pemetrexed Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here